- Regulation
- Technology
- Resources
Latest News
- Industry
-
Fujifilm blazes a trail through pharma’s ethical quagmire
As advancements in research and drug development become more complex, bioethicists are helping companies find their footing along an increasingly ambiguous path.
-
IAPP EU Data Protection Congress 2025: Assessing Europe’s Health Data Space
An animated discussion on the theoretical benefits of the regulation and the gap between legislative dream and market reality.
-
PMCPA concludes Gossamer Bio pre-license promotion breach investigation
The UK watchdog found the biopharma company did not comply with two clauses of the AMPI Code related to a seralutinib meeting display.
-
CMS quietly rolls out new round of Medicare-negotiated drug prices
The second-cycle negotiated-price drugs include medicines to treat cancer, asthma, and metabolic conditions.
-
Australia’s treasurer stops Cosette Pharmaceuticals’ $387.2m takeover bid of Mayne Pharma
The ups and downs of the proposed deal demonstrate the evolving landscape of compliance in the context of geopolitical tensions.
-
Report to US lawmakers flags impact of China pharma on US drug supply chain
The report urges Congress to bolster US pharmaceutical supply-chain resilience and reduce dependence on China.
-
White House, Eli Lilly, Novo Nordisk announce anti-obesity drug deals
The deals will open the Medicare market for these popular drugs to millions of Americans.
-
Health system executives look to AI to implement fundamental changes
A survey of executives finds that healthcare systems must fundamentally transform over the next five years to thrive.